Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HBB | P68871 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1049148 | 0.85 | KDM4E (0.46) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL1052731 | 0.81 | MAPT (0.59) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL21076085 | 0.81 | PTGER4 (0.48) | PTGER4RORCSRC | |
| SCHEMBL21599721 | 0.74 | PTGER4 (0.59) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL24463411 | 0.73 | KDM4E (0.59) | KDM4EHPGDHTTKMT2ATDP1 | |
| SCHEMBL12548590 | 0.71 | KDM4E (0.43) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL13451234 | 0.70 | GPR3 (0.57) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL29556340 | 0.69 | MAPT (0.44) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL19056399 | 0.69 | MAPT (0.44) | KDM4EALDH1A1HPGDMAPTMEN1 | |
| SCHEMBL4892851 | 0.69 | KDM4E (0.65) | KDM4EALDH1A1HPGDMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7875748-B2 | Prepared by reaction of tetraphenylcyclopentadienone with 1,4-diethynyl-2,5-dimethoxybenzene; can be used as a core material for an organic electroluminescence element or other optical devices | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-01-25 | — | — | US | disclosed |
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-09-24 | — | — | US | disclosed |
| US-20050067955-A1 | Compound derived from cyclopentadienone, preparation method thereof and EL element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240062-A1 | COMPOUND DERIVED FROM CYCLOPENTADIENONE, PREPARATION METHOD THEREOF AND EL ELEMENT USING THE SAME | ELP1, CYP51A1, ELOVL1 | KDM4E 1785/4885ALDH1A1 525/4885HPGD 212/4885 |
| US-20050067955-A1 | Compound derived from cyclopentadienone, preparation method thereof and EL element using the same | ELP1, CYP51A1, ELOVL1 | KDM4E 1785/4885ALDH1A1 525/4885HPGD 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.